Form 4: OmniAb Executive VP, Finance and CFO, Kurt A. Gustafson, Reports Share Transactions Following PSU Vesting

OmniAb's Executive VP, Finance and CFO, Kurt A. Gustafson, acquired 27,585 shares through vesting of performance stock units and sold 15,526 shares to cover tax obligations.

Summary

• Kurt A. Gustafson, Executive VP, Finance and CFO of OmniAb, Inc., acquired 27,585 shares of common stock on January 17, 2025, due to the vesting of performance stock units (PSUs).
• These PSUs were granted on July 5, 2022, and vested based on the company's performance through December 31, 2024.
• On January 21, 2025, Mr. Gustafson sold 15,526 shares at a weighted average price of $3.24 per share, with individual sales ranging from $3.21 to $3.27.
• The sale was mandated by the company's equity incentive plan to cover tax withholding obligations related to the PSU vesting.
• Following these transactions, Mr. Gustafson directly owns 212,720 shares of OmniAb common stock.

Sentiment

Score: 6

Explanation: The document reflects standard executive compensation practices and tax-related share sales. While the sale of shares could be perceived negatively, it is a routine transaction and not indicative of a major shift in sentiment.

Positives

• The vesting of performance stock units indicates that the company met certain performance objectives.
• The executive's continued ownership of 212,720 shares demonstrates ongoing alignment with the company's success.

Negatives

• The sale of 15,526 shares, while for tax purposes, could be perceived negatively by some investors.

Risks

• The sale of shares by an executive, even for tax purposes, could create short-term price volatility.
• The company's performance is tied to the vesting of PSUs, which could create pressure to meet targets.

Management Comments

• The Human Capital Management and Compensation Committee of the Board of Directors certified the Issuer's achievement relative to the applicable performance objectives and approved the vesting of the PSUs.
• The sales were mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell-to-cover' transaction and do not represent discretionary trades by the reporting person.

Industry Context

This filing is a routine disclosure of insider transactions, common in publicly traded companies. It reflects the vesting of performance-based equity compensation, a standard practice to align executive interests with company performance.

Comparison to Industry Standards

• The use of performance stock units (PSUs) is a common practice in the biotechnology and pharmaceutical industries, aligning executive compensation with company performance metrics.
• The 'sell-to-cover' mechanism for tax obligations is also a standard practice to simplify tax handling for employees receiving equity compensation.
• Companies like Regeneron, Amgen, and Gilead Sciences also use similar equity compensation structures for their executives.

Stakeholder Impact

• Shareholders may view the vesting of PSUs as a positive sign of the company meeting performance goals.
• The sale of shares by an executive, even for tax purposes, could create short-term price volatility.

Key Dates

Keywords

OmniAb, stock, performance stock units, PSU, vesting, executive, insider trading, tax withholding, share sale, OABI